Literature DB >> 21987390

Malignant melanoma during ustekinumab therapy of Crohn's disease.

Laura M Ehmann, Cornelia Tillack-Schreiber, Stephan Brand, Andreas Wollenberg.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21987390     DOI： 10.1002/ibd.21877

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  7 in total

Review 1.  Ustekinumab for the treatment of Crohn's disease: can it find its niche?

Authors:  Ebby G Simon; Subrata Ghosh; Marietta Iacucci; Gordon W Moran
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

2.  The Efficacy and Evidence-Based Use of Biologics in Children and Adolescents: Using Monoclonal Antibodies and Fusion Proteins as Treatments.

Authors:  Tim Niehues; Tuba Turul Özgür
Journal:  Dtsch Arztebl Int       Date:  2019-10-18       Impact factor: 5.594

3.  Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.

Authors:  Leon Alexander Mclaren Berge; Bettina Kulle Andreassen; Jo Steinson Stenehjem; Trond Heir; Øystein Karlstad; Asta Juzeniene; Reza Ghiasvand; Inger Kristin Larsen; Adele C Green; Marit Bragelien Veierød; Trude Eid Robsahm
Journal:  Clin Epidemiol       Date:  2020-12-18       Impact factor: 4.790

4.  Acute Promyelocytic Leukemia in a Patient With Chronic Continuous Type of Crohn's Disease.

Authors:  Shiori Kinoshita; Satoshi Tanida; Akimi Kawai; Kazuhide Shiraga; Tomoyuki Nakamura; Kana Oiwa; Tomotaka Suzuki; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida
Journal:  J Clin Med Res       Date:  2022-03-25

5.  A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.

Authors:  Marco Vincenzo Lenti; Vivien Dolby; Tanya Clark; Veronica Hall; Suzanne Tattersall; Francesca Fairhurst; Catherine Kenneth; Rachael Walker; Karen Kemp; Simon Borg-Bartolo; Jimmy K Limdi; Jo Taylor; Tristan Townsend; Sree Subramanian; Daniel Storey; Arash Assadsangabi; Catherine Stansfield; Paul Smith; Debra Byrne; Annalisa De Silvestri; Christian P Selinger
Journal:  Aliment Pharmacol Ther       Date:  2021-12-22       Impact factor: 9.524

6.  Emerging dermatological and systemic applications of ustekinumab: beyond its clinical use in psoriasis.

Authors:  Shailendra Kapoor
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-06-21

7.  A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.

Authors:  Emmanouil Charakopoulos; Ioannis Spyrou; Nora-Athina Viniou; Nefeli Giannakopoulou; Sevastianos Hatzidavid; Panagiotis Theodorou Diamantopoulos
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.